Back to results
US 8,796,453 B2Granted
Processes and intermediates for producing azaindoles
AssigneeVertex Pharmaceuticals Incorporated
InventorsGerald J. Tanoury, Young Chun Jung, Derek Magdziak, Adam Looker, Billie J. Kline, Václav Jurcík, Beatriz Dominguez Olmo
Life of this patent
Estimating the term…
Abstract
The present invention relates to processes and intermediates for the preparation of compounds useful as inhibitors of Janus kinases (JAK).
Claims19
A process for preparing a compound of Formula 4:
- wherein:
- R1 is —H, —Cl or —F;
- R2 is —H or —F;
- R3 is —C1-4 aliphatic optionally substituted with 1-5 occurrences of R5;
- R4 is —C1-2 alkyl optionally substituted with 1-3 occurrences of R5;
- or
- R3 and R4 are taken together to form a 3-7 membered carbocyclic or heterocyclic saturated ring optionally substituted with 1-5 occurrences of R5;
- each R5 is independently selected from halogen, —OCH3, —OH, —NO2, —NH2, —SH, —SCH3, —NHCH3, —CN, or unsubstituted —C1-2 aliphatic, or
- two R5 groups, together with the carbon to which they are attached, form a cyclopropyl ring;
- comprising the step of:
- ia) reacting a compound of Formula 1 with a hydrochloride salt of a compound Formula 2,
- in the presence of water, an organic solvent, a base, and a palladium catalyst selected from
- or any combination thereof,
- to generate a compound of Formula 3, and
- ii) deprotecting the compound of Formula 3 to generate the compound of Formula 4.
12 more elements
Dependencies are inferred from the claim text.